Company / Return on Assets (ROA)
Supernus Pharmaceuticals, Inc. Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-2.6%
FY2025
5-year range
-2.6% / 5.4%
FY2021-FY2025
Trend
-149.1%
vs FY2024
Sector context
#66 of 213
Health Care
What the data says
At -2.6%, Supernus Pharmaceuticals, Inc.'s return on assets (roa) ranks #66 of 213 in the Health Care sector. Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -3.5% in FY2016 to 9.7% in FY2019.
Based on SEC 10-K filings.
-2.6% in FY2025 with a 5-year CAGR of -11.1%.
Declined from 0.1% to -2.6% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -6.2pp
- 5-Year Change
- -11.1pp
- 10-Year Change
- -
Sector benchmark
#66 of 213 in Health CareTop 31% of 213This company -2.6% Sector average -24.1%
▼
+89.0% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 149.1% year-over-year.
- Currently 21.5pp above the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2019.
- Lowest return on assets (roa) in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -2.6% | -149.1% |
| FY2024 | 5.4% | +5300.0% |
| FY2023 | 0.1% | -97.2% |
| FY2022 | 3.6% | +13.0% |
| FY2021 | 3.2% | -62.6% |
| FY2020 | 8.4% | -13.3% |
| FY2019 | 9.7% | +4.4% |
| FY2018 | 9.3% | +183.6% |
| FY2017 | 3.3% | +193.2% |
| FY2016 | -3.5% | -147.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026